Your browser doesn't support javascript.
loading
Demonstration of safety of intravenous immunoglobulin in geriatric patients in a long-term, placebo-controlled study of Alzheimer's disease.
Gelmont, David; Thomas, Ronald G; Britt, Jonathan; Dyck-Jones, Jacqueline A; Doralt, Jennifer; Fritsch, Sandor; Brewer, James B; Rissman, Robert A; Aisen, Paul.
Afiliación
  • Gelmont D; Clinical Development, Baxalta US Inc., Westlake Village, CA, USA.
  • Thomas RG; ADCS Alzheimer's Disease Cooperative Study, UCSD, La Jolla, CA, USA.
  • Britt J; Clinical Development, Baxalta US Inc., Westlake Village, CA, USA.
  • Dyck-Jones JA; Clinical Development, Baxalta US Inc., Westlake Village, CA, USA.
  • Doralt J; Clinical Development, Baxalta Innovations GmbH, Vienna, Austria.
  • Fritsch S; Clinical Development, Baxalta Innovations GmbH, Vienna, Austria.
  • Brewer JB; ADCS Alzheimer's Disease Cooperative Study, UCSD, La Jolla, CA, USA.
  • Rissman RA; ADCS Alzheimer's Disease Cooperative Study, UCSD, La Jolla, CA, USA.
  • Aisen P; USC Alzheimer's Therapeutic Research Institute, San Diego, CA, USA.
Alzheimers Dement (N Y) ; 2(2): 131-139, 2016 Jun.
Article en En | MEDLINE | ID: mdl-29067300
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Alzheimers Dement (N Y) Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Alzheimers Dement (N Y) Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos